Leveraging Novel Enzyme Immobilization Technologies for Food Production
Complete the form below to unlock access to ALL audio articles.
Zymtronix, developer of enzyme immobilization technologies, and Tate & Lyle, a global provider of food and beverage ingredients and solutions, have announced a new partnership. This partnership includes an investment by Tate & Lyle in Zymtronix’s enzyme immobilization platform that will enable the US-based company to scale up its production.
Zymtronix’s enzyme immobilization platform is designed to transform ingredient manufacturing by improving the productivity of biocatalysis. This is achieved through the immobilization of enzymes onto magnetic metamaterials to increase the efficiency and sustainability of enzyme-based industrial processes. The technology, originating from Cornell University (Ithaca, NY), has broad applications in the food & beverage, flavor & fragrances, pharmaceutical, chemical and agricultural industries. Tate & Lyle’s investment in Zymtronix aims to enable the company to improve and innovate upon their technology, with the goal of scaling up their platform to support process scale production. Zymtronix is initially working with Tate & Lyle to improve the use of enzymes in the production of certain ingredients and improve cost efficiency.
